Review decisions
Showing 20 results of 2184 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1709310383688
Product Type: Drug
Control Number: 261864
DIN(s): 02491559
Manufacturer: Alexion Pharma Canada
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-02-25
Decision / Authorization Date: 2023-01-06
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1710775270976
Product Type: Drug
Control Number: 271038
DIN(s): 02544903
Manufacturer: Pfizer Canada ULC
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-12-28
Decision / Authorization Date: 2024-01-31
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1712086340348
Product Type: Drug
Control Number: 269372
DIN(s): 02542137
Manufacturer: Sumitomo Pharma Switzerland GmbH
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-11-03
Decision / Authorization Date: 2023-10-10
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1712843981486
Product Type: Drug
Control Number: 268111
DIN(s): 02541742
Manufacturer: Sumitomo Pharma Switzerland GmbH
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-09-23
Decision / Authorization Date: 2023-10-17
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1708630999500
Product Type: Drug
Control Number: 272981
DIN(s): 02511576, 02511584
Manufacturer: Celltrion Healthcare Co., Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-03-02
Decision / Authorization Date: 2024-02-15
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1708530494939
Product Type: Drug
Control Number: 272504
DIN(s): 02446626, 02446634
Manufacturer: Bristol-Myers Squibb Canada
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-02-15
Decision / Authorization Date: 2023-12-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1708454547343
Product Type: Drug
Control Number: 275152
DIN(s): 02459787, 02459795, 02545136, 02545144, 02545152, 02545160
Manufacturer: Novartis Pharmaceuticals Canada Inc
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-05-10
Decision / Authorization Date: 2024-02-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1708464933703
Product Type: Drug
Control Number: 273166
DIN(s): 01981501, 02531577, 02531585
Manufacturer: AbbVie Corporation
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-03-10
Decision / Authorization Date: 2024-02-07
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1708532368148
Product Type: Drug
Control Number: 272746
DIN(s): 02545004
Manufacturer: Bayer Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-02-24
Decision / Authorization Date: 2024-02-02
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1708462789662
Product Type: Drug
Control Number: 266553
DIN(s): 02544334, 02544342
Manufacturer: B. Braun Medical Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-08-22
Decision / Authorization Date: 2024-01-04